Copyright © 2013 The Korean Academy of Geriatrics and Gerontology. / Powered by INFOrang.co, Ltd
Comparison of the outcome between TUEB and HoLEP stratified by prostate weight
| Surgery | Age | Prostate weight estimated by TRUS |
Resected weight (g) | Resection time (min) | Resection efficiency (g/m) | Catheter indwelling time (day) | PSA |
Pre-Operation | Post-Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qmax |
PVR |
IPSS |
Hb |
Qmax (mL/s) | PVR (mL) | IPSS | Hb. | ||||||||||
| Subgroup 1 <50 g | TUEB |
69.2±8.0 | 37.1±8.5 | 28.3±8.1 | 33.8±11.8 | 0.86±0.12 | 4.1±1.4 | 5.8±17.3 | 9.2±5.3 | 108.0±78.2 | 24.3±8.0 | 13.7±1.2 | 17.7±6.9 | 90.7±85.5 | 10.9±4.7 | 13.1±1.4 | |
| HoLEP†† (N=28) | 69.6±7.2 | 39.7±6.5 | 26.6±5.2 | 39.7±7.1 | 0.67±0.08 | 3.7±1.1 | 2.6±2.5 | 8.3±3.6 | 87.7±63.3 | 25.3±6.4 | 13.8±1.0 | 18.1±7.7 | 54.1±48.0 | 12.4±5.2 | 13.3±1.3 | ||
| P-value | .860 | .343 | .681 | .100 | <.001 | .340 | .204 | .564 | .300 | .710 | .837 | .938 | .214 | .312 | .822 | ||
| Subgroup 2 50-80 g | TUEB (N=20) | 71.3±6.4 | 61.5±8.8 | 48.5±8.5 | 61.5±11.9 | 0.79±0.10 | 4.0±1.1 | 6.7±6.5 | 6.8±3.8 | 94.2±62.7 | 26.4±7.2 | 14.0±1.6 | 13.2±3.8 | 86.2±77.5 | 11.4±4.3 | 13.1±1.6 | |
| HoLEP (N=28) | 72.9±7.6 | 61.0±7.5 | 44.3±11.6 | 55.2±14.3 | 0.80±0.04 | 4.3±1.7 | 6.3±7.9 | 6.9±4.1 | 135.1±138.0 | 24.5±7.4 | 13.8±1.2 | 14.2±9.6 | 73.7±65.3 | 11.8±4.7 | 13.2±1.1 | ||
| P-value | .698 | .917 | .119 | .119 | .139 | .796 | .490 | .879 | .517 | .362 | .676 | .842 | .503 | .850 | .933 | ||
| Subgroup 3 >80 g | TUEB (N=11) | 74.0±7.1 | 95.9±15.8 | 81.2±14.8 | 107.6±20.2 | 0.75±0.06 | 4.4±1.4 | 8.6±6.0 | 8.0±3.8 | 168.5±192.7 | 28.0±5.4 | 12.9±2.0 | 11.1±6.3 | 71.9±44.7 | 13.0±4.5 | 11.6±1.6 | |
| HoLEP (N=23) | 71.8±7.2 | 101.5±19.0 | 84.3±15.3 | 93.2±20.7 | 0.91±0.10 | 4.8±2.0 | 20.4±26.7 | 8.5±3.4 | 127.3±48.0 | 27.5±6.1 | 13.5±1.6 | 15.6±9.1 | 88.9±72.7 | 12.0±6.1 | 12.4±1.7 | ||
| P-value | .356 | .387 | .593 | .026 | <.001 | .770 | .204 | .581 | .543 | .985 | .495 | .232 | .685 | .426 | .217 |
*Transrectal ultrasonography; †Prostate specific antigen; ‡Peak flow rate; §Post-voided residual urine; ∥International prostate symptom score; ¶Hemoglobin; **Transurethral enucleation with bipolar; ††Holmium laser enucleation of the prostate.